Positive Brugada challenge test in V1 R-V3 R as a predictor of malignant prognosis in Brugada patients.

Hashemi, Arash; Shahrzad, Shahab; Shahrzad, Sorayya; Saber, Siamak; Taban, Samira; Aslani, Amir; Emkanjoo, Zahra

Hashemi, Arash; Shahrzad, Shahab; Shahrzad, Sorayya; Saber, Siamak; Taban, Samira; Aslani, Amir; Emkanjoo, Zahra.

Affiliation

Hashemi A; Cardiac Electrophysiology Research Center, Rajaei Cardiovascular Research and Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Ann Noninvasive Electrocardiol ; 18(5): 421-6, 2013 Sep.

Article in En | MEDLINE | ID: mdl-24047485

Subject(s)

Anti-Arrhythmia Agents; Brugada Syndrome/diagnosis; Brugada Syndrome/physiopathology; Electrocardiography/methods; Flecainide; Procainamide; Adolescent; Adult; Electrocardiography/drug effects; Female; Humans; Male; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Young Adult

Key words

Brugada syndrome; V1R-V3R; risk stratification

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Procainamide / Flecainide / Electrocardiography / Brugada Syndrome / Anti-Arrhythmia Agents Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Ann Noninvasive Electrocardiol Journal subject: CARDIOLOGIA Year: 2013 Type: Article Affiliation country: Iran

Fulltext

XML

PubMed Links

Search on Google